IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
April 29, 2022 07:00 ET
|
iRadimed Corporation
Reports first quarter 2022 revenue of $12.3 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.22Announces second quarter 2022 financial guidanceIncreases full-year 2022 financial...
IRADIMED CORPORATION Announces Executive Transition
April 28, 2022 16:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today announced that Chris Scott, Chief Financial and Operating Officer, has...
IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th
April 05, 2022 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market...
IRADIMED Announces Special $1.00 Per Share Cash Dividend
February 07, 2022 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors approved a special cash dividend of $1.00 per share...
IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results
February 04, 2022 07:00 ET
|
iRadimed Corporation
Reports fourth quarter 2021 revenue of $11.9 million, GAAP diluted EPS of $0.31 and non-GAAP diluted EPS of $0.33Announces full-year and first quarter 2022 financial guidance WINTER SPRINGS, Fla.,...
IRADIMED CORPORATION to Hold 2021 Fourth Quarter Financial Results Conference Call on February 4th
January 20, 2022 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market...
IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results
October 29, 2021 07:00 ET
|
iRadimed Corporation
Reports third quarter 2021 revenue of $10.9 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Increases full-year 2021 financial guidance WINTER SPRINGS, Fla., Oct. 29,...
IRADIMED CORPORATION to Hold 2021 Third Quarter Financial Results Conference Call on October 29th
October 08, 2021 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 08, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 third quarter financial results before the market...
IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results
July 30, 2021 07:00 ET
|
iRadimed Corporation
Reports second quarter 2021 revenue of $9.8 million, GAAP diluted EPS of $0.12 and non-GAAP diluted EPS of $0.14Issues Q3 and full year 2021 financial guidance WINTER SPRINGS, Fla., July 30, 2021 ...
IRADIMED CORPORATION to Hold 2021 Second Quarter Financial Results Conference Call on July 30th
July 07, 2021 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 07, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 second quarter financial results before the market...